Micron To $150? Here Are 10 Top Analyst Forecasts For Friday
Portfolio Pulse from Avi Kapoor
Top Wall Street analysts have updated their price targets and ratings for several companies, including Travere Therapeutics, Rocket Lab USA, MP Materials, ESCO Technologies, Accenture, Jabil, Agios Pharmaceuticals, Wynn Resorts, Micron Technology, and Udemy. These changes reflect varying outlooks on the companies' future performance.
September 27, 2024 | 12:04 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Baird raised Accenture's price target from $350 to $370, maintaining a Neutral rating. Shares gained 5.6% to close at $355.81.
The raised price target suggests a positive outlook, but the Neutral rating indicates a balanced view, contributing to recent share gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Stephens & Co boosted ESCO Technologies' price target from $135 to $145, maintaining an Overweight rating. Shares rose 1.4% to close at $126.37.
The increased price target and Overweight rating suggest a positive outlook, likely supporting short-term price gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
B of A Securities raised Jabil's price target from $135 to $150, maintaining a Buy rating. Shares gained 11.7% to close at $126.65.
The increased price target and Buy rating indicate strong positive sentiment, likely driving significant short-term price appreciation.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 80
POSITIVE IMPACT
Baird raised MP Materials' price target from $20 to $25, maintaining an Outperform rating. Shares gained 4.6% to close at $16.90.
The raised price target and Outperform rating indicate a strong positive outlook, likely boosting investor confidence and short-term price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Baird cut Micron Technology's price target from $172 to $150, maintaining an Outperform rating. Shares gained 14.7% to close at $109.88.
Despite the price target cut, the maintained Outperform rating and significant share gain suggest strong investor confidence and positive sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 80
POSITIVE IMPACT
Keybanc increased Rocket Lab USA's price target from $8 to $11, maintaining an Overweight rating. Shares gained 0.8% to close at $8.69.
The increased price target and maintained Overweight rating suggest a positive outlook, likely supporting short-term price appreciation.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Morgan Stanley raised Wynn Resorts' price target from $97 to $104, upgrading from Equal-Weight to Overweight. Shares gained 8.2% to close at $91.03.
The raised price target and upgrade to Overweight indicate a positive outlook, likely boosting investor confidence and short-term price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 80
NEUTRAL IMPACT
HC Wainwright & Co. cut the price target for Travere Therapeutics from $23 to $18, maintaining a Buy rating. Shares gained 3.4% to close at $15.04.
The price target cut suggests a less optimistic outlook, but the maintained Buy rating and recent share gain indicate mixed signals for investors.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 80
NEGATIVE IMPACT
Leerink Partners cut Agios Pharmaceuticals' price target from $60 to $56, downgrading from Outperform to Market Perform. Shares fell 2% to close at $48.05.
The price target cut and downgrade to Market Perform suggest a negative outlook, likely contributing to the recent share decline.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Morgan Stanley slashed Udemy's price target from $10 to $7.5, downgrading from Equal-Weight to Underweight. Shares gained 1.3% to close at $8.13.
The significant price target cut and downgrade to Underweight suggest a negative outlook, though shares saw a slight gain.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80